Prudential poised for good full-year figures

Prudential will announce its full-year figures on Tuesday 10 March and the market is anticipating another strong set of results. 

Prudential logo
Source: Bloomberg

Prudential has persevered despite the change in laws to the pension industry which crippled the annuities business; however, the life insurance company has emerged stronger than ever.

The industry was shaken up last year when George Osborne scrapped the laws that forced people to buy annuities, and this lead to a 47% drop in third-quarter single annuity sales at Prudential. The change in legislation comes into effect next month, and the company experienced a 128% jump in sales of drawdown pensions in the first nine months of the year. Prudential’s wide range of pension products has ensured that it is more than covered for the slump in annuity sales.

The London-listed insurer revealed a 17% rise in first-half operating profits, and the resilient US and Asian businesses were the biggest gainers, while the UK division announced a 10% jump in operating profits. The company’s CEO Tidjane Thiam still plans to grow the company ‘aggressively’ in Asia even though the region is slowing. Mr Thaim is still seeking opportunities in the Far East, and the failed takeover attempt of AIA in 2010 means Mr Thaim has unfinished business in Asia.

The consensus for Prudential’s figures is for revenue of £54.48 billion and adjusted net income of £2.44 billion. These estimates equate to a 4% increase in revenue and a 5.3% rise in adjusted net income. The company will also reveal its second-half figures on the same day, and the market is expecting adjusted net income of £1.14 billion, compared with its first-half adjusted income of £1.15 billion.

Equity analysts are very bullish on Prudential, and out of the 25 recommendations, 18 are buys, five are holds, and only two are sells. The average target price is £17.64, which is 6.6% above the current price. Investment banks are also bullish on Legal & General. Out of the 22 ratings 11 are buys, six are holds, and five are sells. The average target price is 265p, which is 3.6% below the current price.

The stock has hit a record high today, and as it is overbought on an hourly basis it might see a pullback to the £16.40 mark; however, the long-term trend points to a move higher in the medium term with £17 as the initial target followed by £18. If £16.40 is punctured, then £16 will become the next level of support and below that is the 100-day moving average of £15.20.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.